Systems vaccinology of the BNT162b2 mRNA vaccine in humans
인간에서 BNT162b2 mRNA 백신의 시스템 백신학
Observational Study
[키워드] Adaptive immune response
Analysis
Antigen
AP-1
approach
B.1.351
B.1.351 variant
BNT162b2
BNT162b2 mRNA vaccine
booster
booster vaccination
CD14
CD16
CD4
CD8 T cell
CD8 T cells
Cluster
Concentration
demonstrated
elicit
Emergency use authorization
evidenced
Frequency
greater
healthy volunteer
Human
immune response
immune responses
immune system
immunization
increase in
Inflammatory
inflammatory monocytes
innate antiviral immunity
innate immune response
innate immune system
interferon
landmark
less
monocyte
Monocytes
mRNA vaccination
mRNA vaccine
mRNA vaccines
myeloid cell
Neutralizing antibodies
neutralizing antibody
Neutralizing antibody response
neutralizing antibody responses
pathway
Pfizer-BioNTech mRNA vaccine
plasma
protective immune response
reduced
robust
SARS-CoV-2
second dose
secondary immunization
significant increases in
single-cell
stimulate
stimulated
System
T cell
T cells
These data
transcription factor
transcription factors
transcriptional
transcriptomics
vaccination
wild-type SARS-CoV-2
[DOI] 10.1038/s41586-021-03791-x PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1038/s41586-021-03791-x PMC 바로가기 [Article Type] Observational Study